Synthesis and biological evaluation of Fotemustine analogues on human melanoma cell lines

European Journal of Medicinal Chemistry

Volumn 38, Issue 3, 2003, Pages 319-324

  Winum, Jean Yves ^a   Bouissière, Jean Luc ^a   Passagne, Isabelle ^a   Evrard, Alexandre ^a   Montero, V éronique ^a   Cuq, Pierre ^a   Montero, Jean Louis ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Chemoresistance; Fotemustine; Melanoma; Nitrososulfamide

Indexed keywords

FOTEMUSTINE; O,O DIETHYL 1 [[N METHYL N' (2 CHLOROETHYL) N' NITROSO]SULFAMIDO]ETHANEPHOSPHONATE; O,O DIETHYL 1 [[N,N' DI (2 CHLOROETHYL) N' NITROSO]SULFAMIDO]ETHANEPHOSPHONATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MELANOMA CELL; PROTEIN EXPRESSION; TUMOR RESISTANCE;

EID: 0037343936     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00014-X     Document Type: Article

References (24)

1. Gnewuch C.T., Sosnovsky G. Chem. Rev. 97:1997;829-1014. and references therein.
2. Ludlum D.B. Teicher B.A. Cancer Therapeutics Experimental and Clinical Agents. 1997;81-92 Humana Press, Totowa, NJ.
3. Johnston T.P., Montgomery J.A. Cancer Treat. Rep. 70:1986;13-30.
4. Ludlum D.B. Mutation Res. 233:1990;117-126.
5. Abdaoui M., Dewynter G., Aouf N., Favre G., Morère A., Montero J.-L. Bioorg. Med. Chem. 4:1996;1227-1235.
6. Abdaoui M., Dewynter G., Montero J.-L. Tetrahedron Lett. 37:1996;5695-5698.
7. Abdaoui M., Dewynter G., Aouf N., Montero J.-L. Phosphorus Sulfur Silicon. 118:1996;39-47.
8. Dewynter G., Abdaoui M., Regainia Z., Montero J.-L. Tetrahedron. 52:1996;14217-14224.
9. Regainia Z., Abdaoui M., Aouf N.E., Dewynter G., Montero J.-L. Tetrahedron. 56:2000;381-387.
10. Abdaoui M., Dewynter G., Toupet L., Montero J.-L. Tetrahedron. 56:2000;2427-2435.
11. Winum J.-Y., Barragan V., Montero J.-L. Tetrahedron Lett. 42:2001;601-603.
12. Lavielle G., Cudennec C., French patent FR 2,536,075, 1982; Chem. Abstr. 96 (1982) 654.
13. Hayes M.T., Bartley J., Parsons P.G., Eaglesham G.F., Prakash A.S. Biochemistry. 36:1997;10646-10654.
14. Seeber A., Binder M., Steiner A., Wolff K., Pehamberger H. Eur. J. Cancer. 34:1998;2129-2131.
15. Petit T., Borel C., Rixe O., Avril M.F., Monnier A., Giroux B., Weil M., Khayat D. Cancer. 77:1996;900-902.
16. Falkson C.I., Falkson G., Falkson H.C. Invest. News Drugs. 12:1994;251-254.
17. Khayat D., Avril M.F., Gerard B., Bertrand P., Bizzari J-P., Cour V. Melanoma Res. 2:1992;147-151. and references therein.
18. Brakenhoff J.P., Commandeur J.N., Wormhoudt L.W., Groot E.J., Vermeulen N.P. Carcinogenesis. 17:1996;715-724.
19. Iliadis A., Launay-Iliadis M.-C., Lucas C., Fety R., Lokiec F., Tranchand B., Milano G. Eur. J. Cancer. 32A:1996;455-460.
20. Christmann M., Pick M., Lage H., Schadendorf D., Kaina B. Int. J. Cancer. 92:2001;123-129.
21. Demir A.S., Tanyeli C., Sesenoglu O., Demiç S. Tetrahedron Lett. 37:1996;407-410.
22. Fischel J.-L., Barbé V., Berlion M., Formento P., Berrile J., Bizzari J.-P., Milano G. Bull. Cancer. 81:1994;599-604 I. Passagne, A. Evrard, P. Depeille, P. Cuq, J.-Y. Winum, V. Barragan, C. Mazeau, L. Vian, J.-P. Cano, D. Cupissol, Proceedings AACR, vol. 43, 93rd Annual Meeting American Association for Cancer Research, San Francisco, CA, 6-10 April, 2002, no. 1303.
23. Evrard A., Cuq P., Ciccolini J., Vian L., Cano J.-P. Br. J. Cancer. 80:1999;1726-1733.
24. Domoradzki J., Pegg A.E., Dolan M.E., Maher V.M., McCormick J.J. Carcinogenesis. 5:1984;1641-1647.